Although chronic nicotine administration does not affect memory, its withdrawal causes massive cognitive deficits. The underlying mechanisms, however, have not been understood. We test the role of cocaine-and amphetamine-regulated transcript peptide (CART), a neuropeptide known for its procognitive properties, in this process. The mice on chronic nicotine treatment/withdrawal were subjected to novel object recognition task. The capability of the animal to discriminate between the novel and familiar objects was tested and represented as discrimination index (DI); reduction in the index suggested amnesia. Nicotine for 49 days had no effect on DI, but 8-hour withdrawal caused a significant reduction, followed by full recovery at 24-hour withdrawal timepoint. Bilateral CART infusion in dorsal hippocampus rescued deficits in DI at 8-hours, whereas CART-antibody infusion into the dorsal hippocampus attenuated the recovery at 24-hours. Commensurate changes were observed in the CART as well as CART mRNA profiles in the hippocampus. CART mRNA expression and the peptide immunoreactivity did not change significantly following chronic nicotine treatment. However, there was a significant reduction at 8-hour withdrawal, followed by a drastic increase in CART immunoreactivity as well as CART mRNA at 24-hour withdrawal, compared with 8-hour withdrawal. Distinct α7-nicotinic receptor immunoreactivity was detected on the hippocampal CART neurons, suggesting cholinergic inputs. An increase in the synaptophysin immunoreactive elements around CART cells in the dentate gyrus, cornu ammonis 3 and subiculum at 24-hour post-withdrawal timepoint suggested neuronal plasticity. CART circuit dynamics in the hippocampus seems to modulate short-term memory associated with nicotine withdrawal.
INTRODUCTION
Addiction to smoking and nicotine consumption are major morbidity and mortality factors worldwide (Gould 2006) . Despite serious attempts at quitting tobacco, relapses are common primarily due to withdrawal-induced craving and dysphoria (Bruijnzeel 2012) . Following nicotine withdrawal, most subjects show impairment of physiological, affective and cognitive functions (Ashare et al. 2013) . These negative consequences are primarily attributed to a constellation of effects mediated by the endogenous cholinergic system that serves as the target for nicotine. While acute administration of nicotine enhances learning and memory, adverse influence was noticed in addicted individuals (Kenney & Gould 2008) . Although chronic nicotine did not affect contextual fear memory (Davis et al. 2005; Gould 2006 ), the cognitive deficits were encountered following nicotine withdrawal (Gould & Wehner 1999; Gould & Higgins 2003; Davis et al. 2005) . Learning and memory deficits, impaired attention and working memory, loss of concentration and recognition have been widely reported following withdrawal of chronic nicotine (Mendrek et al. 2006; Wesnes et al. 2013) . While chronic nicotine essentially targets the hippocampus (Davis & Gould 2009 ), its withdrawal severely impaired hippocampus dependent (contextual fear conditioning), but not independent (cued fear conditioning) memory in the rodents (Hughes, Higgins & Bickel 1994; Gould et al. 2012) . Although these memory deficits were attributed to tolerance or desensitization of the hippocampal nicotinic acetylcholine receptors (nAchRs, Davis et al. 2005) , the underlying mechanism has not been understood.
Previous studies reported a close interaction between nicotine and cocaine-and amphetamine-regulated transcript peptide (CART), known to induce satiety and involve in addiction (Vicentic & Jones 2007) . While CART mediates acute, chronic and withdrawal effects of nicotine on feeding and body weight, acute nicotine treatment increased CART expression in discrete hypothalamic nuclei (Kramer et al. 2007; Dandekar et al. 2011) . Recently, increased CART mRNA levels were noticed in the amygdala following 5 days of nicotine treatment in rats (Kaya et al. 2016) . Although the mechanism underlying CART's role in cognition is yet to be elucidated, various studies report an abundance of CART and its mRNA, in the hippocampus (Koylu et al. 1998; Hurd & Fagergren 2000; Seress et al. 2004) . CART, by upregulating brain-derived neurotrophic factor, promotes survival of the hippocampal neurons (Wu et al. 2006) . CART is present in the granule and mossy cells of the dentate gyrus (DG) and reported to block voltage-gated Ca 2+ channels in the hippocampal slice preparations (Yermolaieva et al. 2001; Seress et al. 2004) . Reduced concentration of CART was noticed in the cerebrospinal fluid in patients of dementia with Lewy bodies (Schultz et al. 2009 ). Central administration of CART enhanced cognitive functions in Morris water maze and object recognition memory tests (Upadhya et al. 2011; Bharne et al. 2016) . In view of these clues, we test the hypothesis that CART is involved in cognitive impairment following nicotine withdrawal. Cognitive defects following tobacco deprivation have been reported in the timeframe of 4 to 8-hours (Parrott et al. 1996; Hendricks et al. 2006) . Impairment of synaptic plasticity induced by paired associative stimulation and transcranial direct current stimulation was detected up to 10-hours of nicotine withdrawal in smokers (Grundey et al. 2012) . In the present study, the mice on chronic nicotine were subjected to novel object recognition (NOR) test at 0, 8 and 24-hour withdrawal timepoints, using 30-minute intertrial interval (ITI). The effects of intrahippocampal (ih) CART and CARTantibody (CART-Ab) treatments were evaluated at 8 and 24-hours, respectively. To determine the neuroanatomical correlates of nicotine treatment/withdrawal, immunohistochemical analysis of the CART elements in hippocampal cornu ammonis 3 (CA3), DG and subiculum was undertaken. With a view to test the possibility of direct cholinergic inputs to the CART cells, the sections containing CA3 and DG were double immunostained by using antibodies against CART and α7-nAchRs. We selected to co-label CART with α7-nAchRs because these receptor engage in LTP (Welsby, Rowan & Anwyl 2006; Kenney & Gould 2008) and learning and memory (Van Kampen et al. 2004) . While the effects of chronic nicotine (or its withdrawal) on synaptic plasticity of CART neurons were probed by using synaptophysin immunocytochemistry, concomitant changes in CART gene expression were investigated by using qRT-PCR. The current study is a maiden attempt at elucidating the role of neuropeptide CART in modulating the temporal changes in short-term recognition memory associated with nicotine withdrawal in mice.
MATERIALS AND METHODS

Animals
Adult, male Swiss albino mice (18-22 g) were group housed in controlled room temperature (25 ± 1°C), relative humidity (50-70 percent) and a 12:12-hour light/dark cycle (lights on 07:00 hours). Food (Trimurti Feeds, Nagpur, India) and drinking water were provided ad libitum except during the test period. Protocols employed in the present study were carried out in accordance with CPCSEA guidelines under the strict compliance of Institutional Animal Ethics Committee, Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, MS, India.
Chronic oral nicotine treatment and withdrawal schedule
The protocol described by Marttila, Raattamaa & Ahtee (2006) and Kivinummi et al. (2011) was employed for chronic nicotine treatment to the mice. The animals were divided randomly into seven different study groups (Table S1 ) and allowed to drink either chronic nicotine or drinking water with 2 percent saccharin sodium salt hydrate (Sigma, St. Louis, MO, USA). (À)-Nicotine tartarate (Sigma) solutions were prepared freshly in drinking water, and the pH was adjusted to 6.8-7.0. The concentration of nicotine in the drinking water was increased gradually every 3-4 days from 50 to 350 μg/ml and thereafter from 350 to 500 μg/ml every 7 days, up to 7 weeks. Administration of nicotine through drinking water mimics several aspects of smoking and elicits comparable plasma nicotine and cotinine concentration, second week onward (Pekonen et al. 1993; Pietila & Ahtee 2000) . At the end of the chronic treatment, the mice were allowed to drink 2 percent saccharin in drinking water without nicotine.
Animal preparation and stereotaxic cannula implantation
The animals were allowed to drink water or nicotine solution for 40 days and then anesthetized with a mixture of ketamine (90 mg/kg) and xylazine (12 mg/kg) (intraperitoneal, ip, route) and stereotaxically implanted with stainless steel guide cannulae, fabricated in-house . The guide cannulae were implanted bilaterally into dorsal hippocampus (DH) at the following coordinates: anteroposterior, À1.58 mm from bregma; mediolateral, ±1.0 mm; ventral, À1.3 mm from skull surface (Paxinos & Franklin 2001) . The details of the procedure and post-surgical care have already been standardized in our laboratory .
The cannulated animals were allowed to recover for 7 days after surgical procedure and kept under observation for neurological or motor deficits like impairment in locomotion, grooming, aggressiveness, handlinginduced hyper-excitability and stereotype behavior. Nicotine administration was continued during the recovery period up to 49 days. Four days post-surgery, the mice were habituated to gentle handling each day, up to the next 5 days.
Drug preparation and administration
After cannulation and recovery from surgery, the control or nicotine-treated (n = 6-7/group) animals were injected with artificial cerebrospinal fluid (aCSF)/ non-immune serum (NIS), CART (10, 25 and 50 ng/mouse) or CART-Ab (1:1000, 1:500 and 1:250 dilutions) via the ih route. The injections and behavioral protocols were conducted between 09:00 and 14:00 hours. CART (54-102 fragments) and mouse monoclonal CART-Ab (generous gift from Drs. Lars Thim & Jes Clausen) raised against CART (54-102) fragment (Thim et al. 1999) were diluted in aCSF. aCSF/NIS, CART or CART-Ab was injected bilaterally in the DH (0.25 μl/side/mouse). Fifteen minutes following the ih injection, individual mouse was subjected to the acquisition phase of NOR test, as described in the succeeding texts.
NOR test
Recognition memory was assessed by using the NOR test. This non-rewarded paradigm is based on the spontaneous exploratory behavior of mice (Ennaceur & Delacour 1988) . The experiments were conducted in an open field chamber (40 × 40 × 30 cm) made of non-transparent plexiglass. The experimental protocol consisted of habituation, acquisition and test phases as detailed in the succeeding texts. First, the mice were habituated to the open field for 10 minutes without any object and then subjected to an acquisition trial (T1) following an interval of 24-hours. During acquisition, the mice were allowed to freely explore two identical objects [square white plastic bottle (length 6 cm, height 12 cm)] for 5 minutes. The objects were positioned 10 cm apart, equidistant from the walls. Thirty minutes later, the animals were resubjected to the testing phase (T2 30-min ). One of the identical objects was replaced with novel object (N) [circular black glass bottle (diameter 6 cm, height 12 cm)] while keeping other familiar object (F) undisturbed. These objects were placed in the same locations as in the acquisition phase (T1). In order to eliminate olfactory cues, chamber and objects were cleaned after each test with cotton swab soaked in 70 percent alcohol. Using two stopwatches, the duration of object exploration was measured by the observer blind to the treatments. Exploration was defined by distinctive behavior like sniffing or touching the object with the nose at a distance of no more than 2 cm. Exploration time for each object was recorded along with the discrimination index (DI) calculated as, DI = (N À F)/(N + F), representing difference in exploration time expressed as a proportion of the total time spent exploring the two objects in testing phase (Ennaceur & Delacour 1988; Bharne et al. 2016) .
Verification of injection site
After completion of the behavioral protocol, the animals were euthanized with an overdose of thiopentone sodium (60 mg/kg, ip, Abbott Pharmaceuticals, Mumbai, India) and brains were dissected out, sliced into 30-μm-thick coronal sections by using cryostat (CM1850, Leica, Germany) to verify the placement of guide cannula in the DH (Fig. S1 ).
Double-labeling immunofluorescence
The effects of chronic nicotine and its withdrawal were evaluated in terms of the expression of CART and synaptophysin (marker for synaptic plasticity) in hippocampus. Disparate groups (n = 5/group) of mice receiving tap water, chronic nicotine or withdrawn from nicotine (following 8 or 24-hour withdrawal) were deeply anesthetized with thiopentone sodium (60 mg/kg, ip), perfused transcardially with heparinized phosphatebuffered saline (PBS; pH 7.45) followed by 4 percent paraformaldehyde in 0.1-M phosphate buffer (pH 7.45). The brains were post-fixed in the same fixative overnight, cryoprotected in 30 percent sucrose solution and serially sectioned on a cryostat (Leica) at 30-μm thickness in coronal plane. The sections were processed for double immunofluorescence labeling with the antibodies against CART and synaptophysin, as described earlier (Bharne et al. 2015) . Briefly, the brain sections passing through hippocampal CA3, DG and subiculum were washed in PBS, treated with 0.5 percent Triton X-100 for 20 minutes and incubated in 5 percent BSA for 60 minutes, followed by incubation in a mixture of rabbit synaptophysin polyclonal antibody (1:500; Merk Millipore, California, USA; Cat no. AB9272) and mouse monoclonal CART-Ab (dilution 1:4000) for 24-hours at 4°C. The sections were rinsed in PBS and incubated in a mixture of Alexa Fluor ® 568 conjugated anti-mouse IgG (Jackson Immunoresearch, West Grove, PA, USA) at 1:400 dilution and Alexa Fluor ® 488 conjugated antirabbit IgG (Jackson Immunoresearch) at 1:400 dilution for 3-hours at room temperature. Finally, the sections were washed in PBS and mounted on poly-L-lysine (Sigma) coated slides and cover slipped with propyl gallate solution. The brains of the control and treated groups of rats were processed simultaneously under identical conditions, and the images were taken immediately after immunostaining to prevent any error due to photobleaching.
Using similar protocol, we double stained sections with antibodies against CART and α7-nAchRs (polyclonal rabbit antibody, dilution 1:200, Santa Cruz Biotechnology Inc, Texas, USA; Cat no. sc-5544, n = 3). In preincubation controls, incubation of primary CART antibody with CART at 10 À5 M for 24-hours completely blocked the CART immunoreaction (Bharne et al. 2016; Borkar et al. 2016) . Omission of the primary antibodies from the incubation medium or replacement with BSA produced no CART or synaptophysin (Bharne et al. 2015) or α7-nAchR immunoreaction. In addition, sections through the frontal cortex of mouse were stained with α7-nAchR antibody and used as positive control (Fig. S2 ). These sections showed characteristic pattern of immunostaining reported elsewhere (Lykhmus et al. 2015) , thus confirming the specificity of the antibody. Thereafter, desired areas were observed under Leica DM-2500 fluorescence microscope by using suitable filter for Alexa Fluor ® and images were captured, adjusted for brightness and contrast and merged by using Adobe PHOTOSHOP CS4 software (Adobe Systems Inc., San Jose, CA, USA).
Morphometric analysis
The method described in our earlier studies (Bharne et al. 2015 (Bharne et al. , 2016 was employed for the relative quantitative analysis of the CART + synaptophysin immunolabeled preparations. Briefly, the transverse sections passing through the hippocampal CA3, DG, subiculum of naïve, chronic nicotine treated (0-hour withdrawal) or 8 and 24-hours following nicotine withdrawal mice were used for the analysis. The percentage (percent) immunoreactive area occupied by CART (red), synaptophysin (green) or CART + synaptophysin (yellow) was evaluated separately by the observer blind to the treatments. The images were digitized and analyzed by using IMAGEJ software (National Institutes of Health, Bethesda, MD, USA). The background was considered as threshold and area occupied by immunostained cells/fibers were measured based on individual pixel intensity in all the treatment groups. The data were collected from the predetermined areas (as demarcated by squares in the Figs 2, 3 & S4) from both the sides of five sections of each brain, drawn from five animals in each group. The morphometric data obtained from five sections of each animal were averaged, thus representing an individual animal. The percent immunoreactive area has been automatically generated by using IMAGEJ software. The data for each group were collated, and mean ± standard error of mean (SEM) was calculated.
Quantitative real-time PCR for mRNA measurements
Quantitative real-time PCR (qRT-PCR) was performed as described previously (Sakharkar et al. 2014 ) with necessary modification for the analysis of two CART transcripts (CART-1 and CART-2, accession no NM_013732 and NM_001081493, respectively). RNA was isolated from the hippocampal tissues from the mice brain (n = 4/ group) by using TRIZOL reagent (Life Technologies, Grand Island, NY, USA) with subsequent DNA removal using DNA-free ™ Kit (Life Technologies). Total RNA was reverse transcribed by using High Capacity cDNA Reverse Transcription kit (Applied Biosystems, USA) according to the manufacturer's instructions. qRT-PCR was performed by using SYBR Green qPCR Master Mix (Applied Biosystems) on STEPONE PCR machine (Applied Biosystems). Primers for transcripts, CART-1 and CART-2, were designed by using NCBI Primer Blast tool, and the primer sequences are as follows:
Polymerase chain reaction conditions included a 5-minute 95°C hold followed by 40 cycles at 95°C for 30 seconds, 60°C for 30 seconds and 72°C for 30 seconds. The housekeeping gene, β-actin, was used as an internal control for sample normalization. Target cDNAs for various genes along with β-actin were analyzed in duplicate for each measurement. The data were extracted from the STEPONE software and analyzed for the relative expression by using 2 ÀΔΔCT method. The results are represented as mean fold changes (±SEM) with respect to control.
Statistical analysis
Data obtained from behavioral as well as immunohistochemistry studies were expressed in mean ± SEM. Statistical significance between exploration time (seconds) for familiar and novel object was compared employing paired t-test. Data for DI were assessed by the one-way analysis of variance (ANOVA) followed by the Bonferroni's multiple comparison test, using PRISM 6.0 (GraphPad Software Inc, CA, USA). Morphometric data based on immunohistochemistry and change in mRNA levels were individually compared by using one-way ANOVA followed by Bonferroni's post-hoc test. Differences were considered significant if P < 0.05.
RESULT
Effect of chronic nicotine treatment and its withdrawal in NOR test
While the animals on drinking water (control) or chronic nicotine spent approximately equal time exploring each of the identical objects in acquisition trial (T1), a significant increase in the exploration time was noted in both the groups for novel object as compared with the familiar object in test phase (T2 30-min ) (t-test for control, P < 0.0001, t = 10.40, df = 5; t-test for chronic nicotine, P < 0.0001, t = 11.59, df = 5). However, at 8-hour nicotine withdrawal timepoint, the animals spent approximately equal time exploring the familiar as well as novel object in test phase (T2 30-min ) (t-test, P = 0.8792, t = 0.1599, df = 5). This suggests impairment of shortterm memory at 8-hour nicotine withdrawal timepoint. On the other hand, the exploration time for the novel object was significantly increased in the mice at 24-hour withdrawal timepoint in test phase as compared with that in the case of familiar object, signifying the restoration of the short-term memory (T2 30-min ) (t-test, P = 0.0015, t = 6.260, df = 5, Fig. 1a) .
Application of one-way ANOVA showed a significant effect on DI [F(3,23) = 13.49, P < 0.0001]. Post-hoc Bonferroni's multiple comparison test revealed that chronic administration of nicotine (0-hour withdrawal) resulted in a non-significant reduction in the DI (P > 0.05). However, a significant reduction in DI was noted at 8-hour nicotine withdrawal timepoint (P < 0.01; Fig. 1b) . No significant difference was observed in the DI of naïve versus 24-hour withdrawal group (P > 0.05). These results suggest restoration of DI at 24-hour nicotine withdrawal timepoint, as compared with that in the 8-hour group (P < 0.01).
Dose-dependent effect of ih-CART on memory deficits at 8-hour nicotine withdrawal timepoint
We evaluated the dose-dependent effect of ih-CART (10, 25 or 50 ng/mouse) at 8-hour nicotine withdrawal timepoint. While 8-hour nicotine withdrawn animals explored novel as well as familiar objects for similar length of time (P = 0.8792, t = 0.1599, df = 5), CART treated (25 or 50 ng/mouse, ih) group explored the novel objects for a longer duration than the familiar object at T2 30-min . The behavior reflected the memory-enhancing effect of CART at 25 and 50 ng dose (t-test for dose 25 ng, P = 0.0129, t = 3.781, df = 5; t-test for dose 50 ng, P = 0.0046, t = 4.863, df = 5, Fig. 1a) . One-way ANOVA showed significant effect of CART on the DI [F(3,23) = 9.498, P < 0.001]. Application of post-hoc Bonferroni's multiple comparison test suggested that CART treatment at 8-hour nicotine withdrawal timepoint significantly increased the DI, as compared with that in aCSF control mice (CART 25 ng/mouse, P < 0.05 and 50 ng/mouse, P < 0.01). However, lower dose of CART (10 ng/mouse) showed no significant change in the DI and was therefore considered as ineffective (P > 0.05, Fig. 1b) .
Effect of CART (50 ng/mouse, ih) per se was also tested in the NOR by using naïve animals that did not receive chronic nicotine. The DI displayed by these mice did not differ significantly from that in aCSF control group (P > 0.05, Fig. S3 ).
Dose-dependent effect of ih-CART-Ab on memory restoration at 24-hour of nicotine withdrawal timepoint Another group of mice was administered with NIS or CART-Ab (1:1000, 1:500 or 1:250 dilutions) at 24-hour nicotine withdrawal timepoint (Fig. 1a) . The NIS-treated mice explored the novel object for significantly longer duration than the familiar object (t-test, P = 0.0015, t = 6.260, df = 5), suggesting recovery of the recognition memory. The animals pretreated with ih-CART-Ab (1:500 or 1:250 dilutions) showed approximately similar preference for both the objects at T2 30-min (t-test for dilution 1:500, P = 0.7758, t = 0.3006, df = 5; t-test for dilution 1:250, P = 0.2955, t = 1.168, df = 5), indicating memory impairment at this timepoint. However, a significant difference was noted in the novel versus familiar object exploration time (t-test, P = 0.0063, t = 4.512, df = 5) following CART-Ab at 1:1000 dilution; the dose was considered ineffective. Oneway ANOVA showed significant effect on DI following CART-Ab treatment [F(3,23) = 17.67, P < 0.001] at 24-hour withdrawal. Post-hoc Bonferroni's multiple comparison test revealed that CART-Ab significantly reduced the DI as compared with 24-hour nicotine withdrawal group at the dilution of 1:500 (P < 0.05) and 1:250 (P < 0.01, Fig. 1b ), but not with 1:1000 dilution (P > 0.05).
Moreover, pre-treatment with CART-Ab (1:250 dilution, ih) to non-nicotine treated naïve animals significantly decreased DI as compared with that in aCSF control animals (P < 0.01, Fig. S3 ).
Effect of chronic nicotine or its withdrawal on CART and synaptophysin immunoreactivity in the CA3, DG and subiculum
One-way ANOVA showed a significant effect of treatments on immunoreactivity profiles in the CA3 [CART, F(3, 19 (Figs 2f, 3f and S4f) in CA3 (Fig. 2) , DG Figure 1 Effect of drinking water (control), chronic nicotine (0-hour) or nicotine withdrawal (NW) and intrahippocampal (ih) injection of aCSF, CART (at 8-hour NW) or CART-antibody (CART-Ab, at 24-hour NW) in NOR task. Exploration behavior (a) and discrimination indices (DI, b) were evaluated during choice trial (T2 30-min ). While chronic nicotine administration did not significantly influence the novel object exploration time, the DI showed a significant reduction in both the parameters at 8-hour timepoint compared with respective controls. However, restoration of memory was noted at 24-hour nicotine withdrawal timepoint. While CART dose-dependently increased the novel object exploration time as well as DI in 8-hour NW animals, both the parameters showed a decrease in mice treated with CART-Ab when compared with that in non-immune serum (NIS) control. *P < 0.05, **P < 0.01 and ***P < 0.001 versus respective familiar object exploration (paired t-test). $ P < 0.01 versus control (drinking water + aCSF/NIS) group. # P < 0.05 and ## P < 0.01 versus 8-hour NW + aCSF. @ P < 0.05 and @@ P < 0.01 versus 24-hour NW + NIS (one-way ANOVA followed by Bonferroni's multiple comparison test) (Fig. 3) and subiculum (Fig. S4) as compared with that in the control mice (Figs 2, 3 and S4; a-c) (all, P > 0.05). A significant reduction in the CART immunoreactive elements (Figs 2g, 3g and S4g) was observed in these brain nuclei at 8-hour nicotine withdrawal timepoint (CA3 and DG, P < 0.05; subiculum, P < 0.01) as compared with that in the chronic nicotine group (0-hour timepoint). However, nicotine withdrawal (8-hours) does not seem Figure 2 Effect of drinking water (naïve, a-c), chronic nicotine (Nic) (d-f) and nicotine withdrawal at 8-hour (g-i) and 24-hour (j-l) timepoints on CART (thin arrows; a, d, g and j), synaptophysin (Syn, arrow-heads; b, e, h and k) and their co-expression (thick arrows; c, f, i and l) in cornu ammonis 3 (CA3) of hippocampus. Percentage area occupied by CART + synaptophysin co-expressing elements (M) was significantly increased at 24-hour withdrawal timepoint versus naïve, chronic nicotine or 8-hour withdrawal animals. Each bar represents the mean ± standard error of mean (n = 5/group). The square (not to scale) indicates the area of CA3 from which the measurements were collated (N). The morphometric data on CART, synaptophysin and colocalized elements were individually analyzed by using one-way ANOVA followed by Bonferroni's multiple comparison test. *P < 0.05 and **P < 0.001 versus chronic nicotine group. and S4l) was noted at 24-hour nicotine withdrawal group as compared with that at 0-hour and 8-hour withdrawal timepoints or in the naïve animals (all, P < 0.001). , synaptophysin (Syn, arrow-heads; b, e, h and k) and their co-expression (thick arrows; c, f, i and l) in dentate gyrus (DG) of hippocampus. Percentage area occupied by CART + synaptophysin co-expressing elements (M) is significantly increased at 24-hour withdrawal timepoint versus naïve, chronic nicotine or 8-hour withdrawal animals. Each bar represents the mean ± standard error of mean (n = 5/group). The square (not to scale) indicates the area of DG from which the measurements were collated (N). The morphometric data on CART, synaptophysin and colocalized elements were individually analyzed by using one-way ANOVA followed by Bonferroni's multiple comparison test. *P < 0.05 and **P < 0.001 versus chronic nicotine group. # P < 0.001 versus Nic. withdrawal 8-hours. $ P < 0.001 versus naïve. D3V, dorsal third ventricle; CA1, CA2 and CA3, cornu ammonis 1, 2 and 3 of hippocampus. Scale bar: 50 μm Effects of chronic nicotine and its withdrawal on CART mRNA levels Quantitative real-time PCR method was employed to estimate the differences in mRNA levels of CART-1 and CART-2 in the hippocampus of mice chronically treated with nicotine and after nicotine withdrawal for 8 and 24-hours (Fig. 4) . One-way ANOVA showed significant effect of treatments on CART-1 mRNA [F(3,15) = 10.95, P < 0.001] and CART-2 mRNA [F(3,15) = 5.283, P < 0.05]. Post-hoc Bonferroni's multiple comparison test revealed that, although the CART transcripts seem to increase in chronic nicotine group, the changes are not statistically significant as compared with those in the control mice on drinking water (P = 0.051). The mRNA levels were significantly reduced following 8-hour withdrawal, particularly in CART-1 levels, as compared with chronic nicotine exposure (P = 0.015). However, expression levels of both the transcripts showed no significant differences at 8-hour withdrawal compared with the naive animals (P > 0.05). At 24-hour withdrawal, however, the CART-1 and 2 levels were significantly augmented as compared with that of naïve control (CART-1, P = 0.009 and CART-2, P = 0.047) or 8-hour nicotine withdrawal animals (CART-1, P = 0.002 and CART-2, P = 0.026).
Colocalization of CART and α7-nAchRs in CA3 and DG
Cocaine-and amphetamine-regulated transcript immunoreactive cell bodies in pyramidal layer of the CA3 and DG region of the hippocampus of naïve mice showed colabeling with α7-nAchRs antibodies (Fig. 5) . However, CART neurons in the subiculum did not show α7-nAchR immunoreactivity (data not shown).
DISCUSSION
General consideration
Addiction to cigarettes or tobacco is primarily attributed to the principal component, nicotine. Acute administration of nicotine produced several positive effects like performance enhancement and cognitive benefits (Heishman, Kleykamp & Singleton 2010) . However, chronic consumption induced maladaptative changes in the brain reward system, eventually leading to nicotine dependence (D'Souza & Markou 2011). The present study permits novel insights in some of the neural changes attributed to chronic nicotine treatment and its withdrawal.
Till date, several authors investigated the effects of chronic nicotine withdrawal on the long-term memory. Studies suggest correlation between withdrawal from chronic nicotine and impairments in contextual fear conditioning (Davis et al. 2005; Andre et al. 2008; Davis & Gould 2009; Gould et al. 2012) . However, Kenney et al. (2011) reported no negative consequences in long-term NOR memory following nicotine withdrawal at 24-or 48-hour timepoints. To our knowledge, there is no information on the effects of nicotine withdrawal on short-term memory. Herein, we investigate temporal changes in the short-term recognition memory, at early nicotine withdrawal timepoints, using NOR with 30-minute ITI, and attempt to define the role of CART The graphs represent the means ± SEM values for fold changes in the CART transcript-1 (CART-1; b) and CART transcript-2 (CART-2; c) in various experimental groups. While both the transcripts showed non-significant (NS) difference across chronic nicotine (0-hour withdrawal) versus that in naïve animals, a significant reduction was noted at 8-hour withdrawal timepoint in CART-1, but not CART-2, compared with chronic nicotine group. However, both the transcripts showed a rebound increase at 24-hour withdrawal timepoint compared with that in 8-hour withdrawal or naïve animals. Hippocampal tissues were processed for each individual animal separately. qRT-PCR was performed in duplicate for each sample along with β-actin as an internal control and analyzed the relative expression by using 2 ÀΔΔCT method (n = 4/group) in the process. Our results show that the CART system may respond to nicotine in certain discrete components of the hippocampus and modulate memory engrams. While chronic administration of nicotine did not affect the recognition memory, the mice at 8-hour withdrawal timepoint showed short-term memory impairment and reduced CART expression. The memory deficit was recovered following injection of CART via the ih route. Further, at 24-hour withdrawal timepoint, the animals showed normal recognition memory and a concomitant increase in hippocampal CART expression, suggesting an important role for the peptide in memory restoration in the framework of hippocampus. The involvement of hippocampus in object recognition has been debated. Several studies show no effect of hippocampal lesion (Good et al. 2007; Barker & Warburton 2011) or hippocampal protein synthesis inhibition (Balderas et al. 2008 ) on recognition memory in NOR. On the contrary, hippocampal inactivation (using NMDA antagonist, GABA mimetics or lidocaine treatment) or its lesion impaired long-term and short-term memory storage in animals (Clark, Zola & Squire 2000; Cohen & Stackman 2015) . In spite of these contradictions, most studies confirm that familiarity test (in NOR) is a function of perirhinal cortex and recollection of memories is processed in the hippocampus, and neither of these structures are solely responsible for object recognition memory assessed in NOR task (Ranganath et al. 2004; Cohen & Stackman 2015) . Recent study from our laboratory showed that neural circuit across entorhinal cortex, perirhinal cortex and hippocampus may play an important role in recognition memory (Bharne et al. 2016) . The study revealed that CART promotes long-term memory within the framework of hippocampus and may engage NMDA-ERK signaling.
The current study compliments the earlier data and shows that CART in the hippocampus may also modulate short-term memory.
Chronic nicotine and learning and memory
Although acute doses of nicotine improved learning and memory in humans and animals (Kenney & Gould 2008; Myers et al. 2008; Heishman et al. 2010) , chronic nicotine did not facilitate fear memory retention (Gould & Wehner 1999; Gould & Higgins 2003; Davis et al. 2005) . On similar lines, we found no improvement in the recognition memory following chronic nicotine. The effect may be due to desensitization of nAchRs as suggested in earlier studies (Collins et al. 1994; Gould et al. 2014) . Interestingly, Gould et al. (2014) attributed the withdrawal effects to upregulation of high affinity but desensitized nAchR population in DH.
In the hippocampus of mammals, nicotinic receptors containing α7 as well as α4β2 subunits are prominently expressed (Picciotto et al. 2000) . The role of α7-nAchRs in the improvement of learning and memory in rats is well established (Van Kampen et al. 2004) . Nicotine enhanced LTP in the perforant pathway primarily by activation of α7-nAchRs, whereas LTP in the Schafer collaterals was attributed to desensitization of α7-nAchRs and activation of non α7-nAchRs (Welsby et al. 2006; Kenney & Gould 2008) . Because α7-subunit containing nicotinic receptors were detected on CART neurons in the CA3 and DG regions of the hippocampus, we suggest that these neurons may be under cholinergic regulation. However, we cannot rule out the involvement of other subtypes of nAchRs, as also suggested by Kenney & Gould (2008) . 
Nicotine withdrawal and learning and memory
Accumulating data suggest that withdrawal following chronic nicotine treatment impaired hippocampus dependent contextual and trace fear conditioning (Davis et al. 2005; Raybuck & Gould 2009 ), spatial object recognition and the performance in Morris water maze and radial-arm maze tasks (Levin et al. 1990) . In the present study, because the animal failed to discriminate the novel object at 8-hour withdrawal timepoint in NOR performed with 30-minute ITI, we infer that withdrawal following chronic nicotine may induce short-term memory impairment. However, full recovery of the memory was noted at the 24-hour post-withdrawal timepoint.
In the non-nicotine mice injected with CART, there was no improvement in the memory. However, CART improved the cognitive performance of the mice, at 8-hour nicotine withdrawal timepoint. This suggests that loss of memory in 8-hour nicotine withdrawn animals is due to CART insufficiency. On the other hand, the recovery of memory in mice noticed at 24-hour nicotine withdrawal timepoint was attenuated by ih CART-Ab administration. These data underscore the causal role of CART in short-term recognition memory formation. The immunohistochemistry results support these observations. Although there was no significant difference in CART immunoreactivity across the DG, CA3 and subiculum regions between water-fed control and mice on chronic nicotine (0-hour withdrawal), diminished CART neuronal population was noted at 8-hour withdrawal timepoint. However, a significant increase in CART expression was observed at 24-hour nicotine withdrawal timepoint in all these hippocampal subdivisions. Because mossy fibers and perforant pathways innervating CA3 region regulate the acquisition and retrieval of the memory, respectively (Lee & Kesner 2004) , we suggest that CART in these circuits may promote both the actions at 24-hour withdrawal timepoint. However, functional integration of CART cells in these pathways needs to be elucidated further.
As stated earlier, CART mRNA and peptide are widely distributed in the brain (Douglass, McKinzie & Couceyro 1995; Koylu et al. 1998) and under modulation of the agents like cocaine and amphetamine (Douglass et al. 1995) , 5-HT4 receptor agonist, BIMU8 (Jean et al. 2007 ) and caffeine (Hu et al. 2014) . In the present study, CART gene expression changed following chronic nicotine withdrawal (8 and 24-hour timepoints). Chronic administration of nicotine (0-hour timepoint) did not significantly alter the expression of both the CART transcripts in the hippocampus. However, at 8-hour withdrawal timepoint, CART-1 transcript was found to be significantly reduced as compared with that in chronic nicotine group. Upregulation of both the transcripts was noted at 24-hour withdrawal timepoint as compared with naive or 8-hour withdrawal animals. This suggests that nicotine withdrawal can transiently influence the expression of CART mRNA. We may recall that nicotine withdrawal is known to alter the gene expression in rat hippocampal neurons (Houdi, Dasgupta & Kindy 1998) .
Although the pattern of changes in the two CART mRNA transcripts showed similar trends, some differences were noticed. At the 8-hour nicotine withdrawal time point, we observed low abundance of CART-1, but not CART-2. This correlates well with the amnesia seen at this timepoint. These observations open-up the possibility of differential role of the CART proteins in the memory functions. Our immunohistochemical data reflect the temporal changes seen in mRNA expression. While decreased CART immunoreactivity and mRNA were noted at 8-hour withdrawal timepoint, a significant increase in CART peptide, as well as mRNA expression, was observed at 24-hour nicotine withdrawal timepoint in the hippocampus. However, after chronic nicotine (0-hour timepoint), non-significant decrease in CART immunoreactivity as well as a non-significant increase in CART mRNA were noted.
Neuronal plasticity in chronic nicotine treatment and withdrawal
Synaptophysin is located on the synaptic vesicles, regulates vesicular endocytosis and is widely used as a presynaptic marker (Kwon & Chapman 2011) . There is a distinct increase in the synaptophysin immunoreactivity in the hippocampus, particularly on the CART neurons in CA1, DG and subiculum in the nicotine withdrawn animals at 24-hour timepoint. Indeed, the expression is far more than at 0-hour timepoint or in the naive animals (all, P < 0.001). Robust increase in CART mRNA expression was also seen at 24-hour time point. Because this temporally matched with memory restoration, we suggest a role for CART in the process.
Hypothesized mechanism
In the present study, we show that the nicotine treatment/withdrawal influenced the expression of CART mRNA and the peptide in CA3, DG and subiculum. While the occurrence of α7-nAchRs on CART neurons in CA3 and DG suggests possibilities of cholinergic regulation, studies based on pharmacological or genetic tools will be needed to precisely define the nature of involvement. Although long-term nicotine administration is known to upregulate nicotine receptor subtype α4β2 in hippocampus, cortex, striatum and midbrain, α7-nAchR expression did not change (Sparks & Pauly 1999; Yohn, Turner & Blendy 2014) . Indeed, this may explain the lack of change in CART expression and display of intact memory following chronic nicotine treatment. However, nicotine withdrawal at 8-hour timepoint resulted in drastic reduction in CART immunoreactivity and memory impairment, which may be attributed to reduction in nicotine receptors at this timepoint. Reduced expression of α7-nAchR following nicotine withdrawal leading to impaired learning and memory have been reported in humans (Mamede et al. 2007) . At 24-hour timepoint, however, increased nAchR was noted (Yohn et al. 2014) , which, in turn, might stimulate CART expression and probably contributes to restoration of memory in the mice (Fig. S5) .
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article. Photomicrograph shows the passage of the guide cannula (#) directed bilaterally into the dorsal hippocampus (B). CA1, cornu ammonis 1; DG, dentate gyrus. Scale bar = 500 μm. Figure S2 Photomicrographs of coronal section showing α7-nicotine receptor (α7-nAchR) immunoreactivity (A, red) in the prefrontal cortex (PFC) of control mice. Note that omission of antibody (negative control, B) did not produce the immunoreaction in the PFC. Scale bar = 100 μm. Figure S3 Effect of intrahippocampal (ih) injection of aCSF (control), CART and CART-antibody (CART-Ab) on exploration time (A) and discrimination index (B) in NOR task at choice trial (T2 30-min ) in naïve animals. Both aCSF and CART-treated animals showed higher exploration for novel as compared with familiar object, indicating intact memory. Interestingly, no significant difference in the novel versus familiar object exploration was observed following CART-Ab treatment, suggesting memory impairment. While CART administration did not significantly increase the discrimination index, a drastic reduction was noted following CART-Ab treatment compared with control mice. *P < 0.01; **P < 0.001 versus respective familiar object exploration (paired t-test).
# P < 0.001 versus control (one-way ANOVA followed by Bonferroni's multiple comparison test; n = 6/group). is significantly increased at 24-hr withdrawal time-point vs naïve, chronic Nic. or 8-hr withdrawal animals. Each bar represents the mean ± standard error of mean (n = 5/group). Square (not to scale) indicates the area of subiculum from which the measurements were collated (N). The morphometric data on CART, synaptophysin and colocalized elements were individually analyzed using one-way ANOVA followed by Bonferroni's multiple comparison test. *P < 0.01, **P < 0.001 vs chronic nicotine group. # P < 0.001 vs Nic. withdrawal 8-hr. $ P < 0.001 vs naïve. D3V, dorsal third ventricle. Scale bar: 50 μm. Figure S5 Hypothesized mechanism underlying the effects of chronic nicotine and nicotine withdrawal on the memory in mice. In naïve animals (A), hippocampal α7-nAchR (Picciotto et al. 2000 ) present on CART neurons may regulate CART expression. Chronic nicotine treatment may not significantly change α7-nAchR expression (Sparks and Pauly, 1999, B) or induce a change in CART level, thus leaving the memory intact. However, nicotine withdrawal at 8-hr time-point may drastically reduce nicotine receptors (Mamede et al. 2007 , C) on CART neurons, leading to decrease CART expression and impaired learning and memory. At 24-hr withdrawal time-point, a robust increase in nAchR (Yohn et al. 2014, D) might stimulate CART expression and restoration of memory. Table S1 Summary of treatments
